PL3223838T3 - Kompozycje i sposoby przygotowywania i stosowania żółtego kiwi - Google Patents
Kompozycje i sposoby przygotowywania i stosowania żółtego kiwiInfo
- Publication number
- PL3223838T3 PL3223838T3 PL15863825.4T PL15863825T PL3223838T3 PL 3223838 T3 PL3223838 T3 PL 3223838T3 PL 15863825 T PL15863825 T PL 15863825T PL 3223838 T3 PL3223838 T3 PL 3223838T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- methods
- use therefor
- gold kiwifruit
- kiwifruit compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ70245414 | 2014-11-28 | ||
| NZ70640515 | 2015-03-27 | ||
| PCT/NZ2015/050200 WO2016085356A1 (en) | 2014-11-28 | 2015-11-27 | Gold kiwifruit compositions and methods of preparation and use therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3223838T3 true PL3223838T3 (pl) | 2025-05-26 |
Family
ID=56074755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15863825.4T PL3223838T3 (pl) | 2014-11-28 | 2015-11-27 | Kompozycje i sposoby przygotowywania i stosowania żółtego kiwi |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US10512663B2 (enExample) |
| EP (2) | EP4548775A3 (enExample) |
| JP (3) | JP7330667B2 (enExample) |
| KR (2) | KR20230156436A (enExample) |
| CN (3) | CN106999523A (enExample) |
| BR (1) | BR112017011078B1 (enExample) |
| CA (2) | CA2967263A1 (enExample) |
| DK (1) | DK3223838T3 (enExample) |
| ES (1) | ES3023661T3 (enExample) |
| FI (1) | FI3223838T3 (enExample) |
| MY (1) | MY188290A (enExample) |
| NZ (1) | NZ732197A (enExample) |
| PL (1) | PL3223838T3 (enExample) |
| PT (1) | PT3223838T (enExample) |
| SI (1) | SI3223838T1 (enExample) |
| WO (1) | WO2016085356A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10512663B2 (en) * | 2014-11-28 | 2019-12-24 | Anagenix Ip Limited | Gold kiwifruit compositions and methods of preparation and use therefor |
| KR101833503B1 (ko) * | 2016-12-26 | 2018-03-05 | 주식회사 엠디헬스케어 | 만성폐쇄성폐질환자에서 세균 메타게놈 분석을 통한 폐암 진단방법 |
| KR101833348B1 (ko) * | 2016-12-26 | 2018-03-02 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 유방암 진단방법 |
| KR101940426B1 (ko) * | 2016-12-28 | 2019-01-18 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 대장종양 진단 방법 |
| KR101942197B1 (ko) * | 2016-12-28 | 2019-01-24 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 전립선질환 진단 방법 |
| US11413318B2 (en) * | 2017-06-06 | 2022-08-16 | Sami-Sabinsa Group Limited | Compositions and methods for management of atrophic gastritis and colitis |
| WO2019075273A1 (en) * | 2017-10-11 | 2019-04-18 | Gu Jennifer L | INTESTINAL HEALTH COMPOSITIONS |
| KR102130485B1 (ko) * | 2017-10-13 | 2020-07-06 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 알츠하이머치매 진단방법 |
| KR102007786B1 (ko) * | 2017-10-18 | 2019-08-07 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 두경부암 진단방법 |
| CA3088630A1 (en) | 2017-12-15 | 2019-06-20 | Solarea Bio, Inc. | Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome |
| KR101940950B1 (ko) | 2018-01-23 | 2019-01-21 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 담관암 진단방법 |
| KR101944662B1 (ko) * | 2018-02-14 | 2019-02-01 | 주식회사 엠디헬스케어 | 세균 메타게놈 분석을 통한 뇌졸중 진단방법 |
| US11980647B2 (en) | 2018-09-05 | 2024-05-14 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
| EP3846830A4 (en) | 2018-09-05 | 2022-07-06 | Solarea Bio, Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULOSKELETAL DISEASES |
| CN109288104B (zh) * | 2018-11-12 | 2023-09-01 | 方家铺子(莆田)绿色食品有限公司 | 一种桂圆鲜果挂黄处理设备及其处理方法 |
| US11622974B2 (en) | 2019-01-18 | 2023-04-11 | C.P. Kelco U.S., Inc. | Prebiotic composition and its use |
| CN110279814A (zh) * | 2019-06-10 | 2019-09-27 | 湖北虹玮农业有限公司 | 一种用于中老年慢性便秘的功能食品 |
| US11684645B2 (en) * | 2019-11-26 | 2023-06-27 | Tci Co., Ltd. | Actinidia chinensis Planch ferment and use thereof |
| WO2022115709A2 (en) * | 2020-11-30 | 2022-06-02 | January, Inc. | Methods and composition for treating metabolic syndrome |
| US20220233151A1 (en) * | 2021-01-22 | 2022-07-28 | Ethicon Llc | Bariatric surgery post-surgical monitoring |
| KR102543549B1 (ko) * | 2021-01-26 | 2023-06-15 | 주식회사 다솔마임마케팅사업부 | 칼라만시 발포정 및 그 제조 방법 |
| CN113521109A (zh) * | 2021-06-28 | 2021-10-22 | 广州知易生物科技有限公司 | 解纤维素拟杆菌在预防和/或治疗炎症性肠病中的应用 |
| CN116076711A (zh) * | 2021-11-05 | 2023-05-09 | 百岳特生物技术(上海)有限公司 | 益生质组合物及其用途 |
| US12343366B2 (en) * | 2021-11-05 | 2025-07-01 | Tci Co., Ltd. | Prebiotic composition and method for improving intestinal health using the same |
| WO2023092150A1 (en) | 2021-11-22 | 2023-05-25 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
| US20230190834A1 (en) | 2021-12-21 | 2023-06-22 | Solarea Bio, Inc. | Immunomodulatory compositions comprising microbial entities |
| JP7701899B2 (ja) * | 2022-09-14 | 2025-07-02 | 花王株式会社 | クロロゲン酸類吸収量の予測方法 |
| KR102536627B1 (ko) * | 2022-09-30 | 2023-05-30 | (주)바이텍 | 키위 발효물을 포함하는 알코올성 간손상 예방 또는 개선용 조성물 |
| US20250195588A1 (en) * | 2023-12-18 | 2025-06-19 | First Day Life, Inc. | Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics |
| US20250195594A1 (en) * | 2023-12-18 | 2025-06-19 | First Day Life Inc. | Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics |
| NL2038369B1 (en) * | 2024-07-31 | 2025-03-06 | Sunbird Company Ltd | A composition of natural kiwifruit powder and postbiotics and its use in constipation improvement |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US22355A (en) | 1858-12-21 | sherwood | ||
| JP2750767B2 (ja) * | 1990-02-21 | 1998-05-13 | 雪印乳業株式会社 | 新規糖アルコール |
| NZ235972A (en) | 1990-11-06 | 1995-04-27 | Amaranathan Balasingham | Fruit product by soft pulping after skin removal |
| CN1107308A (zh) * | 1994-02-25 | 1995-08-30 | 中国癌症研究基金会 | 猕猴桃天然营养口服液 |
| JPH10313822A (ja) * | 1997-05-20 | 1998-12-02 | Pola Chem Ind Inc | 腸内細菌叢改善剤及びそれを含有する組成物 |
| AT503521A1 (de) * | 2006-05-05 | 2007-11-15 | Omnica Gmbh | Verwendung eines extraktes von kiwi-frucht |
| NZ554991A (en) * | 2007-05-03 | 2009-11-27 | Vital Food Processors Ltd | Powdered kiwifruit extract compositions for the treatment of digestive dysfunction and/or gastrointestinal tract disorders |
| USPP22355P3 (en) * | 2009-06-30 | 2011-12-20 | Zespri Group Limited | Kiwifruit plant named ‘ZESY002’ |
| MY162344A (en) * | 2010-01-28 | 2017-06-15 | Ab-Biotics S A | Probiotic composition for use in the treatment of bowel inflammation |
| US10512663B2 (en) * | 2014-11-28 | 2019-12-24 | Anagenix Ip Limited | Gold kiwifruit compositions and methods of preparation and use therefor |
-
2015
- 2015-11-27 US US15/529,734 patent/US10512663B2/en active Active
- 2015-11-27 EP EP25151514.4A patent/EP4548775A3/en active Pending
- 2015-11-27 ES ES15863825T patent/ES3023661T3/es active Active
- 2015-11-27 CA CA2967263A patent/CA2967263A1/en active Pending
- 2015-11-27 DK DK15863825.4T patent/DK3223838T3/da active
- 2015-11-27 CA CA3200468A patent/CA3200468A1/en active Pending
- 2015-11-27 FI FIEP15863825.4T patent/FI3223838T3/fi active
- 2015-11-27 WO PCT/NZ2015/050200 patent/WO2016085356A1/en not_active Ceased
- 2015-11-27 PL PL15863825.4T patent/PL3223838T3/pl unknown
- 2015-11-27 CN CN201580064171.3A patent/CN106999523A/zh active Pending
- 2015-11-27 SI SI201532064T patent/SI3223838T1/sl unknown
- 2015-11-27 EP EP15863825.4A patent/EP3223838B1/en active Active
- 2015-11-27 MY MYPI2017701750A patent/MY188290A/en unknown
- 2015-11-27 KR KR1020237037806A patent/KR20230156436A/ko active Pending
- 2015-11-27 JP JP2017547368A patent/JP7330667B2/ja active Active
- 2015-11-27 BR BR112017011078-4A patent/BR112017011078B1/pt active IP Right Grant
- 2015-11-27 CN CN202310572047.4A patent/CN116763830A/zh active Pending
- 2015-11-27 PT PT158638254T patent/PT3223838T/pt unknown
- 2015-11-27 CN CN202310308827.8A patent/CN116270773A/zh active Pending
- 2015-11-27 NZ NZ732197A patent/NZ732197A/en unknown
- 2015-11-27 KR KR1020177017760A patent/KR102599549B1/ko active Active
-
2019
- 2019-11-06 US US16/675,936 patent/US11090348B2/en active Active
-
2021
- 2021-06-11 US US17/345,478 patent/US11642386B2/en active Active
-
2022
- 2022-02-07 JP JP2022017185A patent/JP7471668B2/ja active Active
-
2023
- 2023-03-22 US US18/188,045 patent/US20240091291A1/en active Pending
-
2024
- 2024-04-03 JP JP2024060245A patent/JP2024088715A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286316A (en) | New micro-dystrophins and related method of use | |
| SI3223838T1 (sl) | Pripravki zlatega kivija ter metode priprave in uporabe | |
| ZA201801511B (en) | Flavonoid compositions and methods of use | |
| IL250415B (en) | Antibodies against pd-l and methods of using them | |
| ZA201701244B (en) | Carrier-antibody compositions and methods of making and using the same | |
| GB2535423B (en) | Cementing compositions and methods | |
| HUE056172T2 (hu) | Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra | |
| ZA201701909B (en) | Trichoderma compositions and methods of use | |
| SG11201708114SA (en) | Ophthalmic compositions and methods of use therefor | |
| IL256381A (en) | Cryo-deposit preparations and methods for their preparation | |
| PL3288379T3 (pl) | Kompozycje peptydowe i sposoby stosowania | |
| EP3136879A4 (en) | Concentrated protein compositions and methods of their making and use | |
| EP3190886A4 (en) | Compositions and methods of use thereof | |
| SG11201803284YA (en) | Novel method of use and compositions | |
| EP3207029A4 (en) | Tryptamide compositions and methods of use | |
| IL261794A (en) | Preparations and methods for using them | |
| GB2537518B (en) | Settable compositions and methods of use | |
| AU2014905067A0 (en) | Compositions and methods of use | |
| AU2014902829A0 (en) | Compositions and Methods of Use |